{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:01:19Z","timestamp":1776492079381,"version":"3.51.2"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine","award":["National Medical Education Letter [2022] No. 75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No. 75"]}]},{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine","award":["National Medical Education Letter [2022] No. 75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No. 75"]}]},{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine","award":["National Medical Education Letter [2022] No. 75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No. 75"]}]},{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine","award":["National Medical Education Letter [2022] No. 75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No. 75"]}]},{"name":"Shanghai Clinical Key Specialty Construction Project . High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["shslczdzk05201"],"award-info":[{"award-number":["shslczdzk05201"]}]},{"name":"Shanghai Clinical Key Specialty Construction Project . High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["shslczdzk05201"],"award-info":[{"award-number":["shslczdzk05201"]}]},{"name":"Shanghai Clinical Key Specialty Construction Project . High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["shslczdzk05201"],"award-info":[{"award-number":["shslczdzk05201"]}]},{"name":"Shanghai Clinical Key Specialty Construction Project . High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["shslczdzk05201"],"award-info":[{"award-number":["shslczdzk05201"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-202365"],"award-info":[{"award-number":["zyyzdxk-202365"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-202365"],"award-info":[{"award-number":["zyyzdxk-202365"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-202365"],"award-info":[{"award-number":["zyyzdxk-202365"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-202365"],"award-info":[{"award-number":["zyyzdxk-202365"]}]},{"name":"Peak Plateau Team Project of Shanghai University of Traditional Chinese Medicine","award":["30304114341"],"award-info":[{"award-number":["30304114341"]}]},{"name":"Peak Plateau Team Project of Shanghai University of Traditional Chinese Medicine","award":["30304114341"],"award-info":[{"award-number":["30304114341"]}]},{"name":"Peak Plateau Team Project of Shanghai University of Traditional Chinese Medicine","award":["30304114341"],"award-info":[{"award-number":["30304114341"]}]},{"name":"Peak Plateau Team Project of Shanghai University of Traditional Chinese Medicine","award":["30304114341"],"award-info":[{"award-number":["30304114341"]}]},{"name":"Shanghai Famous Traditional Chinese Medicine Academic Experience Research Studio Construction Project","award":["SHGZS-2017019"],"award-info":[{"award-number":["SHGZS-2017019"]}]},{"name":"Shanghai Famous Traditional Chinese Medicine Academic Experience Research Studio Construction Project","award":["SHGZS-2017019"],"award-info":[{"award-number":["SHGZS-2017019"]}]},{"name":"Shanghai Famous Traditional Chinese Medicine Academic Experience Research Studio Construction Project","award":["SHGZS-2017019"],"award-info":[{"award-number":["SHGZS-2017019"]}]},{"name":"Shanghai Famous Traditional Chinese Medicine Academic Experience Research Studio Construction Project","award":["SHGZS-2017019"],"award-info":[{"award-number":["SHGZS-2017019"]}]},{"name":"Shanghai Baiyulan Talent Plan Pujiang Project","award":["23PJD095"],"award-info":[{"award-number":["23PJD095"]}]},{"name":"Shanghai Baiyulan Talent Plan Pujiang Project","award":["23PJD095"],"award-info":[{"award-number":["23PJD095"]}]},{"name":"Shanghai Baiyulan Talent Plan Pujiang Project","award":["23PJD095"],"award-info":[{"award-number":["23PJD095"]}]},{"name":"Shanghai Baiyulan Talent Plan Pujiang Project","award":["23PJD095"],"award-info":[{"award-number":["23PJD095"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02386-6","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T15:49:53Z","timestamp":1745596193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Research progress on N6-methyladenosine and non-coding RNA in multiple myeloma"],"prefix":"10.1007","volume":"16","author":[{"given":"Xiaoqi","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"2386_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04906-w","author":"J Bao","year":"2024","unstructured":"Bao J, Xu T, Wang W, Xu H, Chen X, Xia R. N6-methyladenosine-induced mir-182-5p promotes multiple myeloma tumorigenesis by regulating camk2n1. Mol Cell Biochem. 2024. https:\/\/doi.org\/10.1007\/s11010-023-04906-w.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"2386_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2024.2315385","volume":"21","author":"E Crespo-Garcia","year":"2024","unstructured":"Crespo-Garcia E, Bueno-Costa A, Esteller M. Single-cell analysis of the epitranscriptome: rna modifications under the microscope. RNA Biol. 2024;21(1):1\u20138. https:\/\/doi.org\/10.1080\/15476286.2024.2315385.","journal-title":"RNA Biol"},{"issue":"2","key":"2386_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/2211536606666170511102219","volume":"6","author":"AE Erson-Bensan","year":"2017","unstructured":"Erson-Bensan AE, Begik O. M6a modification and implications for micrornas. Microrna. 2017;6(2):97\u2013101. https:\/\/doi.org\/10.2174\/2211536606666170511102219.","journal-title":"Microrna"},{"issue":"46","key":"2386_CR4","doi-asserted-by":"publisher","first-page":"e35984","DOI":"10.1097\/MD.0000000000035984","volume":"102","author":"X Qiu","year":"2023","unstructured":"Qiu X, Chen D, Huang S, Chen N, Wu J, Liang S, Peng P, Qin M, Huang J, Liu S. Identification and verification of m6a-related mirnas correlated with prognosis and immune microenvironment in colorectal cancer. Medicine (Baltimore). 2023;102(46):e35984. https:\/\/doi.org\/10.1097\/MD.0000000000035984.","journal-title":"Medicine (Baltimore)"},{"issue":"1\u20132","key":"2386_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41417-020-0193-8","volume":"28","author":"Z Yang","year":"2021","unstructured":"Yang Z, Jiang X, Zhang Z, Zhao Z, Xing W, Liu Y, Jiang X, Zhao H. Hdac3-dependent transcriptional repression of foxa2 regulates fto\/m6a\/myc signaling to contribute to the development of gastric cancer. Cancer Gene Ther. 2021;28(1\u20132):141\u201355. https:\/\/doi.org\/10.1038\/s41417-020-0193-8.","journal-title":"Cancer Gene Ther"},{"key":"2386_CR6","doi-asserted-by":"publisher","first-page":"1268090","DOI":"10.3389\/fimmu.2023.1268090","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bin T, Tang J, Xu XJ, Lin C, Lu B, Sun TT. Construction of an acute myeloid leukemia prognostic model based on m6a-related efferocytosis-related genes. Front Immunol. 2023;14:1268090. https:\/\/doi.org\/10.3389\/fimmu.2023.1268090.","journal-title":"Front Immunol"},{"issue":"1","key":"2386_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41420-023-01698-2","volume":"9","author":"J Li","year":"2023","unstructured":"Li J, Zhu Z, Zhu Y, Li J, Li K, Zhong W. Mettl3-mediated m6a methylation of c1qa regulates the rituximab resistance of diffuse large b-cell lymphoma cells. Cell Death Discov. 2023;9(1):405. https:\/\/doi.org\/10.1038\/s41420-023-01698-2.","journal-title":"Cell Death Discov"},{"issue":"8","key":"2386_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41419-023-06036-z","volume":"14","author":"Y Jia","year":"2023","unstructured":"Jia Y, Yu X, Liu R, Shi L, Jin H, Yang D, Zhang X, Shen Y, Feng Y, Zhang P, Yang Y, Zhang L, Zhang P, Li Z, He A, Kong G. Prmt1 methylation of wtap promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6a modification of ndufs6. Cell Death Dis. 2023;14(8):512. https:\/\/doi.org\/10.1038\/s41419-023-06036-z.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2386_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10565-024-09904-2","volume":"40","author":"Y Wu","year":"2024","unstructured":"Wu Y, Luo Y, Yao X, Shi X, Xu Z, Re J, Shi M, Li M, Liu J, He Y, Du X. Kiaa1429 increases foxm1 expression through ythdf1-mediated m6a modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma. Cell Biol Toxicol. 2024;40(1):58. https:\/\/doi.org\/10.1007\/s10565-024-09904-2.","journal-title":"Cell Biol Toxicol"},{"issue":"7","key":"2386_CR10","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00277-023-05283-6","volume":"102","author":"X Huang","year":"2023","unstructured":"Huang X, Yang Z, Li Y, Long X. M6a methyltransferase mettl3 facilitates multiple myeloma cell growth through the m6a modification of bzw2. Ann Hematol. 2023;102(7):1801\u201310. https:\/\/doi.org\/10.1007\/s00277-023-05283-6.","journal-title":"Ann Hematol"},{"key":"2386_CR11","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.leukres.2024.107451","volume":"141","author":"K Zhu","year":"2024","unstructured":"Zhu K, Gou F, Zhao Z, Xu K, Song J, Jiang H, Zhang F, Yang Y, Li J. Circ_0005615 enhances multiple myeloma progression through interaction with eif4a3 to regulate map3k4 m6a modification mediated by alkbh5. Leuk Res. 2024;141:107451. https:\/\/doi.org\/10.1016\/j.leukres.2024.107451.","journal-title":"Leuk Res"},{"issue":"1","key":"2386_CR12","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.gendis.2024.101214","volume":"12","author":"J Xu","year":"2025","unstructured":"Xu J, Wang Y, Ren L, Li P, Liu P. Igf2bp1 promotes multiple myeloma with chromosome 1q gain via increasing cdc5l expression in an m(6)a-dependent manner. Genes Dis. 2025;12(1):101214. https:\/\/doi.org\/10.1016\/j.gendis.2024.101214.","journal-title":"Genes Dis"},{"key":"2386_CR13","doi-asserted-by":"publisher","first-page":"1383232","DOI":"10.3389\/fcell.2024.1383232","volume":"12","author":"S Jiang","year":"2024","unstructured":"Jiang S, Gao L, Li J, Zhang F, Zhang Y, Liu J. N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating dna repair. Front Cell Dev Biol. 2024;12:1383232. https:\/\/doi.org\/10.3389\/fcell.2024.1383232.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2386_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)a methyltransferase mettl3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335\u201345. https:\/\/doi.org\/10.1016\/j.molcel.2016.03.021.","journal-title":"Mol Cell"},{"issue":"1","key":"2386_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40164-024-00480-z","volume":"13","author":"W Zhou","year":"2024","unstructured":"Zhou W, Li S, Wang H, Zhou J, Li S, Chen G, Guan W, Fu X, Nervi C, Yu L, Li Y. A novel aml1-eto\/fto positive feedback loop promotes leukemogenesis and ara-c resistance via stabilizing igfbp2 in t(8;21) acute myeloid leukemia. Exp Hematol Oncol. 2024;13(1):9. https:\/\/doi.org\/10.1186\/s40164-024-00480-z.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2386_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12964-023-01321-y","volume":"22","author":"Z Mei","year":"2024","unstructured":"Mei Z, Shen Z, Pu J, Liu Q, Liu G, He X, Wang Y, Yue J, Ge S, Li T, Yuan Y, Yang L. Nat10 mediated ac4c acetylation driven m(6)a modification via involvement of ythdc1-ldha\/pfkm regulates glycolysis and promotes osteosarcoma. Cell Commun Signal. 2024;22(1):51. https:\/\/doi.org\/10.1186\/s12964-023-01321-y.","journal-title":"Cell Commun Signal"},{"key":"2386_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-024-00731-5","author":"R Yang","year":"2024","unstructured":"Yang R, Yang C, Su D, Song Y, Min J, Qian Z, Shen X, Li J, Su H. Mettl3-mediated rangap1 promotes colorectal cancer progression through the mapk pathway by recruiting ythdf1. Cancer Gene Ther. 2024. https:\/\/doi.org\/10.1038\/s41417-024-00731-5.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"2386_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10142-023-01279-7","volume":"24","author":"J Jiang","year":"2023","unstructured":"Jiang J, Zhu J, Qiu P, Ni J, Zhu W, Wang X. Hnrnpa2b1-mediated m6a modification of foxm1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of lcn2. Funct Integr Genomics. 2023;24(1):3. https:\/\/doi.org\/10.1007\/s10142-023-01279-7.","journal-title":"Funct Integr Genomics"},{"issue":"1","key":"2386_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18388\/abp.2020_6017","volume":"70","author":"J Jin","year":"2023","unstructured":"Jin J, Fu L, Hong P, Feng W. Malat-1 regulates the aml progression by promoting the m6a modification of zeb1. Acta Biochim Pol. 2023;70(1):37\u201343. https:\/\/doi.org\/10.18388\/abp.2020_6017.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"2386_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s11658-022-00406-9","volume":"27","author":"L Wang","year":"2022","unstructured":"Wang L, Yi X, Xiao X, Zheng Q, Ma L, Li B. Exosomal mir-628-5p from m1 polarized macrophages hinders m6a modification of circfut8 to suppress hepatocellular carcinoma progression. Cell Mol Biol Lett. 2022;27(1):106. https:\/\/doi.org\/10.1186\/s11658-022-00406-9.","journal-title":"Cell Mol Biol Lett"},{"issue":"5","key":"2386_CR21","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s10565-021-09690-1","volume":"39","author":"F Che","year":"2023","unstructured":"Che F, Ye X, Wang Y, Wang X, Ma S, Tan Y, Mao Y, Luo Z. Mettl3 facilitates multiple myeloma tumorigenesis by enhancing yy1 stability and pri-microrna-27 maturation in m(6)a-dependent manner. Cell Biol Toxicol. 2023;39(5):2033\u201350. https:\/\/doi.org\/10.1007\/s10565-021-09690-1.","journal-title":"Cell Biol Toxicol"},{"issue":"8","key":"2386_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/15384101.2023.2170521","volume":"22","author":"CJ Chen","year":"2023","unstructured":"Chen CJ, Huang JY, Huang JQ, Deng JY, Shangguan XH, Chen AZ, Chen LT, Wu WH. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing mettl3-mediated m6a methylation of thrap3, rbm25, and usp4. Cell Cycle. 2023;22(8):986\u20131004. https:\/\/doi.org\/10.1080\/15384101.2023.2170521.","journal-title":"Cell Cycle"},{"issue":"16","key":"2386_CR23","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.18632\/aging.204965","volume":"15","author":"R Wei","year":"2023","unstructured":"Wei R, Cao Y, Wu H, Liu X, Jiang M, Luo X, Deng Z, Wang Z, Ke M, Zhu Y, Chen S, Gu C, Yang Y. Inhibition of vcp modulates nf-kappab signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation. Aging (Albany NY). 2023;15(16):8220\u201336. https:\/\/doi.org\/10.18632\/aging.204965.","journal-title":"Aging (Albany NY)"},{"key":"2386_CR24","doi-asserted-by":"publisher","DOI":"10.1530\/JME-23-0130","author":"X Li","year":"2024","unstructured":"Li X, Fan C, Wang J, Li P, Xu X, Guo R, Wei J, Cheng Y, Lin H, Fu X. Follicle-stimulating hormone accelerates osteoclast migration by enhancing methyltransferase-like 3-mediated m6a methylation of cathepsin k. J Mol Endocrinol. 2024. https:\/\/doi.org\/10.1530\/JME-23-0130.","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"2386_CR25","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.ymthe.2021.12.012","volume":"30","author":"A Xu","year":"2022","unstructured":"Xu A, Zhang J, Zuo L, Yan H, Chen L, Zhao F, Fan F, Xu J, Zhang B, Zhang Y, Yin X, Cheng Q, Gao S, Deng J, Mei H, Huang Z, Sun C, Hu Y. Fto promotes multiple myeloma progression by posttranscriptional activation of hsf1 in an m(6)a-ythdf2-dependent manner. Mol Ther. 2022;30(3):1104\u201318. https:\/\/doi.org\/10.1016\/j.ymthe.2021.12.012.","journal-title":"Mol Ther"},{"issue":"4","key":"2386_CR26","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41417-022-00429-6","volume":"30","author":"C Wang","year":"2023","unstructured":"Wang C, Li L, Li M, Wang W, Jiang Z. Fto promotes bortezomib resistance via m6a-dependent destabilization of sod2 expression in multiple myeloma. Cancer Gene Ther. 2023;30(4):622\u20138. https:\/\/doi.org\/10.1038\/s41417-022-00429-6.","journal-title":"Cancer Gene Ther"},{"issue":"6","key":"2386_CR27","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.7150\/ijbs.64943","volume":"18","author":"T Yu","year":"2022","unstructured":"Yu T, Yao L, Yin H, Teng Y, Hong M, Wu Q. Alkbh5 promotes multiple myeloma tumorigenicity through inducing m(6)a-demethylation of sav1 mrna and myeloma stem cell phenotype. Int J Biol Sci. 2022;18(6):2235\u201348. https:\/\/doi.org\/10.7150\/ijbs.64943.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2386_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41388-021-02095-8","volume":"41","author":"J Qu","year":"2022","unstructured":"Qu J, Hou Y, Chen Q, Chen J, Li Y, Zhang E, Gu H, Xu R, Liu Y, Cao W, Zhang J, Cao L, He J, Cai Z. Rna demethylase alkbh5 promotes tumorigenesis in multiple myeloma via traf1-mediated activation of nf-kappab and mapk signaling pathways. Oncogene. 2022;41(3):400\u201313. https:\/\/doi.org\/10.1038\/s41388-021-02095-8.","journal-title":"Oncogene"},{"issue":"1","key":"2386_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12967-022-03750-8","volume":"20","author":"C Jia","year":"2022","unstructured":"Jia C, Guo Y, Chen Y, Wang X, Xu Q, Zhang Y, Quan L. Hnrnpa2b1-mediated m6a modification of tlr4 mrna promotes progression of multiple myeloma. J Transl Med. 2022;20(1):537. https:\/\/doi.org\/10.1186\/s12967-022-03750-8.","journal-title":"J Transl Med"},{"issue":"1","key":"2386_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","volume":"14","author":"F Jiang","year":"2021","unstructured":"Jiang F, Tang X, Tang C, Hua Z, Ke M, Wang C, Zhao J, Gao S, Jurczyszyn A, Janz S, Beksac M, Zhan F, Gu C, Yang Y. Hnrnpa2b1 promotes multiple myeloma progression by increasing akt3 expression via m6a-dependent stabilization of ilf3 mrna. J Hematol Oncol. 2021;14(1):54. https:\/\/doi.org\/10.1186\/s13045-021-01066-6.","journal-title":"J Hematol Oncol"},{"issue":"20","key":"2386_CR31","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41388-023-02675-w","volume":"42","author":"R Liu","year":"2023","unstructured":"Liu R, Miao J, Jia Y, Kong G, Hong F, Li F, Zhai M, Zhang R, Liu J, Xu X, Wang T, Liu H, Hu J, Yang Y, He A. N6-methyladenosine reader ythdf2 promotes multiple myeloma cell proliferation through egr1\/p21(cip1\/waf1)\/cdk2-cyclin e1 axis-mediated cell cycle transition. Oncogene. 2023;42(20):1607\u201319. https:\/\/doi.org\/10.1038\/s41388-023-02675-w.","journal-title":"Oncogene"},{"issue":"2","key":"2386_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/iub.2678","volume":"75","author":"J Wang","year":"2023","unstructured":"Wang J, Zuo Y, Lv C, Zhou M, Wan Y. N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma. IUBMB Life. 2023;75(2):137\u201348. https:\/\/doi.org\/10.1002\/iub.2678.","journal-title":"IUBMB Life"},{"issue":"35","key":"2386_CR33","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1038\/s41388-021-01939-7","volume":"40","author":"S Song","year":"2021","unstructured":"Song S, Fan G, Li Q, Su Q, Zhang X, Xue X, Wang Z, Qian C, Jin Z, Li B, Zhuang W. Idh2 contributes to tumorigenesis and poor prognosis by regulating m6a rna methylation in multiple myeloma. Oncogene. 2021;40(35):5393\u2013402. https:\/\/doi.org\/10.1038\/s41388-021-01939-7.","journal-title":"Oncogene"},{"issue":"1","key":"2386_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11033-024-09217-x","volume":"51","author":"D Ramasamy","year":"2024","unstructured":"Ramasamy D, Thippannah M, Maharajan H, Balaiah M, Seshadri RA, Kodous AS, Herceg Z, Mehta A, Rao A, Mani S. Transcriptome-wide profiling identifies colon cancer-associated m6a transcripts and potential rna methyl modifiers. Mol Biol Rep. 2024;51(1):299. https:\/\/doi.org\/10.1007\/s11033-024-09217-x.","journal-title":"Mol Biol Rep"},{"key":"2386_CR35","doi-asserted-by":"publisher","DOI":"10.3233\/CH-232063","author":"X Men","year":"2024","unstructured":"Men X, Hu A, Xu T. Circlzic regulates ox-ldl-induced huvec cell proliferation and apoptosis via micro-330-5p\/notch2 axis in atherosclerosis. Clin Hemorheol Microcirc. 2024. https:\/\/doi.org\/10.3233\/CH-232063.","journal-title":"Clin Hemorheol Microcirc"},{"key":"2386_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-024-01047-3","author":"H Zhou","year":"2024","unstructured":"Zhou H, Wu R, Li H. Silencing circldlrad3 inhibits lung cancer progression by regulating the mir-497-5p\/pfkp axis. Mol Biotechnol. 2024. https:\/\/doi.org\/10.1007\/s12033-024-01047-3.","journal-title":"Mol Biotechnol"},{"key":"2386_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae008","author":"W Zhang","year":"2024","unstructured":"Zhang W, Yang Q, Qian D, Zhao K, Tang C, Ju S. Deregulation of circrna hsa_circ_0009109 promotes tumor growth and initiates autophagy by sponging mir-544a-3p in gastric cancer. Gastroenterol Rep (Oxf). 2024. https:\/\/doi.org\/10.1093\/gastro\/goae008.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"2386_CR38","doi-asserted-by":"publisher","first-page":"216743","DOI":"10.1016\/j.canlet.2024.216743","volume":"588","author":"Z Wei","year":"2024","unstructured":"Wei Z, Zhang C, Song Y, Han D, Liu J, Song X, Chao F, Wang S, Xu G, Chen G. Circube3a(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear translocation to suppress prostate cancer metastasis. Cancer Lett. 2024;588:216743. https:\/\/doi.org\/10.1016\/j.canlet.2024.216743.","journal-title":"Cancer Lett"},{"issue":"1","key":"2386_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-024-02971-7","volume":"43","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu Z, Zhong Z, Ji Y, Guo H, Wang W, Chen C. A tumor suppressor protein encoded by circkeap1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity. J Exp Clin Cancer Res. 2024;43(1):52. https:\/\/doi.org\/10.1186\/s13046-024-02971-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"2386_CR40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s13770-023-00585-2","volume":"20","author":"J Zhou","year":"2023","unstructured":"Zhou J, Xu M, Chen Z, Huang L, Wu Z, Huang Z, Liu L. Circ_spef2 regulates the balance of treg cells by regulating mir-16-5p\/bach2 in lymphoma and participates in the immune response. Tissue Eng Regen Med. 2023;20(7):1145\u201359. https:\/\/doi.org\/10.1007\/s13770-023-00585-2.","journal-title":"Tissue Eng Regen Med"},{"issue":"4","key":"2386_CR41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2174\/1574892818666221207115016","volume":"18","author":"YL Tang","year":"2023","unstructured":"Tang YL, Su JY, Luo JS, Zhang LD, Zheng LM, Liang C, Wang LN, Li Y, Fan Z, Huang DP, Sun P, Luo Z, Qi NH, Lan JJ, Zhang XL, Huang LB, Luo XQ. Gene expression network and circ_0008012 promote progression in mll\/af4 positive acute lymphoblastic leukemia. Recent Pat Anticancer Drug Discov. 2023;18(4):538\u201348. https:\/\/doi.org\/10.2174\/1574892818666221207115016.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"1","key":"2386_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13018-023-03832-3","volume":"18","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Duan H, Yang W, Liu H, Tao X, Zhang Y. Circ_0005615 restrains the progression of multiple myeloma through modulating mir-331-3p and igf1r regulatory cascade. J Orthop Surg Res. 2023;18(1):356. https:\/\/doi.org\/10.1186\/s13018-023-03832-3.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"2386_CR43","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1080\/16078454.2021.1974199","volume":"26","author":"L Liu","year":"2021","unstructured":"Liu L, Zhang F, Li J. Circrna circ_0001821 predicts an unfavorable prognosis and promotes the proliferation of multiple myeloma. Hematology. 2021;26(1):716\u201323. https:\/\/doi.org\/10.1080\/16078454.2021.1974199.","journal-title":"Hematology"},{"issue":"1","key":"2386_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/dna.2023.0288","volume":"43","author":"F Li","year":"2024","unstructured":"Li F, Liu J, Miao J, Hong F, Liu R, Lv Y, Yang Y, He A, Wang J. Circular rna circxpo1 promotes multiple myeloma progression by regulating mir-495-3p\/dna damage-induced transcription 4 axis. DNA Cell Biol. 2024;43(1):39\u201355. https:\/\/doi.org\/10.1089\/dna.2023.0288.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"2386_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-019-1071-9","volume":"38","author":"Y Feng","year":"2019","unstructured":"Feng Y, Zhang L, Wu J, Khadka B, Fang Z, Gu J, Tang B, Xiao R, Pan G, Liu J. Circrna circ_0000190 inhibits the progression of multiple myeloma through modulating mir-767-5p\/mapk4 pathway. J Exp Clin Cancer Res. 2019;38(1):54. https:\/\/doi.org\/10.1186\/s13046-019-1071-9.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"2386_CR46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.arcmed.2023.05.002","volume":"54","author":"P Wang","year":"2023","unstructured":"Wang P, Zhang Y, Lin Q, Zhou J, Lv X, Song Y. Hsa_circ_0111738 inhibits tumor progression and angiogenesis in multiple myeloma by sponging mir-1233-3p to regulate hif-1 signaling pathway. Arch Med Res. 2023;54(4):299\u2013309. https:\/\/doi.org\/10.1016\/j.arcmed.2023.05.002.","journal-title":"Arch Med Res"},{"issue":"1","key":"2386_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40164-024-00582-8","volume":"13","author":"J Min","year":"2024","unstructured":"Min J, Mao J, Shi H, Peng Y, Xu X, Guo M, Tang X, Yang Y, Gu C. Cul4a-ddb1-circrfwd2 e3 ligase complex mediates the ubiquitination of p27 to promote multiple myeloma proliferation. Exp Hematol Oncol. 2024;13(1):116. https:\/\/doi.org\/10.1186\/s40164-024-00582-8.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2386_CR48","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1002\/hem3.34","volume":"8","author":"M Papatsirou","year":"2024","unstructured":"Papatsirou M, Kontos CK, Ntanasis-Stathopoulos I, Malandrakis P, Sideris DC, Fotiou D, Liacos CI, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E. Exploring the molecular biomarker utility of circcct3 in multiple myeloma: a favorable prognostic indicator, particularly for r-iss ii patients. Hemasphere. 2024;8(1):e34. https:\/\/doi.org\/10.1002\/hem3.34.","journal-title":"Hemasphere"},{"key":"2386_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2023.101057","author":"J Gao","year":"2024","unstructured":"Gao J, Qu J, Xiao B, Huang Q, Zhu C, Dai Z, Wu K, Li L, Zeng T. The diagnostic value of serum lncrna catg00000112921.1 as a marker of multiple myeloma. Curr Probl Cancer. 2024. https:\/\/doi.org\/10.1016\/j.currproblcancer.2023.101057.","journal-title":"Curr Probl Cancer"},{"issue":"4","key":"2386_CR50","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/hon.3157","volume":"41","author":"X Long","year":"2023","unstructured":"Long X, Wen F, Li J, Huang X. Lncrna fezf1-as1 accelerates multiple myeloma progression by regulating igf2bp1\/bzw2 signaling. Hematol Oncol. 2023;41(4):694\u2013703. https:\/\/doi.org\/10.1002\/hon.3157.","journal-title":"Hematol Oncol"},{"issue":"5","key":"2386_CR51","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4149\/neo_2022_211102N1559","volume":"69","author":"CS Wang","year":"2022","unstructured":"Wang CS, Zhang XB, Zhu XT, Chen RS. Nbr2\/mir-561-5p\/dlc1 axis inhibited the development of multiple myeloma by activating the ampk\/mtor pathway to repress glycolysis. Neoplasma. 2022;69(5):1165\u201374. https:\/\/doi.org\/10.4149\/neo_2022_211102N1559.","journal-title":"Neoplasma"},{"key":"2386_CR52","doi-asserted-by":"publisher","first-page":"110474","DOI":"10.1016\/j.cellsig.2022.110474","volume":"100","author":"T Ma","year":"2022","unstructured":"Ma T, Chen Y, Yi ZG, Liu J, Li YH, Bai J, Tie WT, Huang M, Zhu XF, Wang J, Du J, Zuo XQ, Li Q, Lin FL, Tang L, Guo J, Xiao HW, Lei Q, Ma XL, Li LJ, Zhang LS. Norad promotes multiple myeloma cell progression via bmp6\/p-erk1\/2 axis. Cell Signal. 2022;100:110474. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110474.","journal-title":"Cell Signal"},{"issue":"1","key":"2386_CR53","doi-asserted-by":"publisher","first-page":"2422153","DOI":"10.1080\/16078454.2024.2422153","volume":"29","author":"Y Xu","year":"2024","unstructured":"Xu Y, Wang T, Wan J, Ma D, Zhang H, Cheng D, Yang J, Wang M. Long non-coding rna neat1 promotes multiple myeloma malignant transformation via targeting mir-485-5p\/abcb8. Hematology. 2024;29(1):2422153. https:\/\/doi.org\/10.1080\/16078454.2024.2422153.","journal-title":"Hematology"},{"issue":"10\u201311","key":"2386_CR54","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/carcin\/bgad053","volume":"44","author":"H Yan","year":"2023","unstructured":"Yan H, Gao S, Xu A, Zuo L, Zhang J, Zhao Y, Cheng Q, Yin X, Sun C, Hu Y. Malat1 regulates network of microrna-15a\/16-vegfa to promote tumorigenesis and angiogenesis in multiple myeloma. Carcinogenesis. 2023;44(10\u201311):760\u201372. https:\/\/doi.org\/10.1093\/carcin\/bgad053.","journal-title":"Carcinogenesis"},{"issue":"2","key":"2386_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1158\/1541-7786.MCR-23-0282","volume":"22","author":"QM Wang","year":"2024","unstructured":"Wang QM, Lian GY, Sheng SM, Xu J, Ye LL, Min C, Guo SF. Exosomal lncrna neat1 inhibits nk-cell activity to promote multiple myeloma cell immune escape via an ezh2\/pbx1 axis. Mol Cancer Res. 2024;22(2):125\u201336. https:\/\/doi.org\/10.1158\/1541-7786.MCR-23-0282.","journal-title":"Mol Cancer Res"},{"issue":"Pt B","key":"2386_CR56","doi-asserted-by":"publisher","first-page":"113080","DOI":"10.1016\/j.intimp.2024.113080","volume":"142","author":"Y Song","year":"2024","unstructured":"Song Y, Guo N, Zi F, Zheng J, Cheng J. Lncrna h19 plays a role in multiple myeloma via interacting with hnrnpa2b1 to stabilize bet proteins by targeting osteoclasts and osteoblasts. Int Immunopharmacol. 2024;142(Pt B):113080. https:\/\/doi.org\/10.1016\/j.intimp.2024.113080.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2386_CR57","doi-asserted-by":"publisher","first-page":"2422154","DOI":"10.1080\/16078454.2024.2422154","volume":"29","author":"J Ning","year":"2024","unstructured":"Ning J, Yang R, Wang H, Ma H, Cui L. Lncrna malat1 silencing represses cxcl12-induced proliferation, invasion, and homing behavior in multiple myeloma by inhibiting cxcr4. Hematology. 2024;29(1):2422154. https:\/\/doi.org\/10.1080\/16078454.2024.2422154.","journal-title":"Hematology"},{"issue":"11","key":"2386_CR58","doi-asserted-by":"publisher","first-page":"260","DOI":"10.14715\/cmb\/2023.69.11.39","volume":"69","author":"M Zhou","year":"2023","unstructured":"Zhou M, Deng T, Tan Y, Liu L, Wang M. Mir-26 inhibits proliferation and promotes apoptosis of multiple myeloma cells by targeting bnip3. Cell Mol Biol (Noisy-le-grand). 2023;69(11):260\u20135. https:\/\/doi.org\/10.14715\/cmb\/2023.69.11.39.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"2","key":"2386_CR59","doi-asserted-by":"publisher","first-page":"389","DOI":"10.18388\/abp.2020_6644","volume":"70","author":"X Liu","year":"2023","unstructured":"Liu X, Qin L, Li W, Fei F. Microrna-1179 targets epiregulin (ereg) regulates the proliferation and metastasis of human multiple myeloma cells. Acta Biochim Pol. 2023;70(2):389\u201393. https:\/\/doi.org\/10.18388\/abp.2020_6644.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"2386_CR60","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1186\/s13018-023-04399-9","volume":"18","author":"S Long","year":"2023","unstructured":"Long S, Long S, He H, Luo L, Liu M, Ding T. Exosomal mir-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting sox6. J Orthop Surg Res. 2023;18(1):937. https:\/\/doi.org\/10.1186\/s13018-023-04399-9.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"2386_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1158\/0008-5472.CAN-23-0189","volume":"84","author":"H Zhang","year":"2024","unstructured":"Zhang H, Du Z, Tu C, Zhou X, Menu E, Wang J. Hypoxic bone marrow stromal cells secrete mir-140-5p and mir-28-3p that target spred1 to confer drug resistance in multiple myeloma. Cancer Res. 2024;84(1):39\u201355. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0189.","journal-title":"Cancer Res"},{"issue":"11","key":"2386_CR62","doi-asserted-by":"publisher","first-page":"e7387","DOI":"10.1002\/cam4.7387","volume":"13","author":"R Zhang","year":"2024","unstructured":"Zhang R, Zhang D, Luo Y, Sun Y, Duan C, Yang J, Wei J, Li X, Lu Y, Lai X. Mir-34a promotes the immunosuppressive function of multiple myeloma-associated macrophages by dampening the tlr-9 signaling. Cancer Med. 2024;13(11):e7387. https:\/\/doi.org\/10.1002\/cam4.7387.","journal-title":"Cancer Med"},{"key":"2386_CR63","doi-asserted-by":"publisher","first-page":"1250355","DOI":"10.3389\/fonc.2023.1250355","volume":"13","author":"D Mikulski","year":"2023","unstructured":"Mikulski D, Nowicki M, Drozdz I, Misiewicz M, Koscielny KP, Okonski K, Krawiec K, Perdas E, Wierzbowska A, Fendler W. High serum mir-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation. Front Oncol. 2023;13:1250355. https:\/\/doi.org\/10.3389\/fonc.2023.1250355.","journal-title":"Front Oncol"},{"key":"2386_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116065","author":"AI Gkioka","year":"2024","unstructured":"Gkioka AI, Tsota M, Koudouna A, Gkiokas A, Mitropoulou CA, Palaiokrassa A, Alexandropoulos A, Papadatou-Gigante M, Bartzi V, Tryfou TM, Sfikakis PP, Dedoussis GV, Kyrtsonis MC. Circulating mir-16 and mir-21 levels in multiple myeloma: prognostic significance of survival and response to lenalidomide treatment. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25116065.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2386_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s11658-023-00515-z","volume":"28","author":"M Song","year":"2023","unstructured":"Song M, Yao H, Sun Z, Chen D, Xu X, Long G, Wu L, Hu W. Mettl3\/ythdc1-medicated m6a modification of circrna3634 regulates the proliferation and differentiation of antler chondrocytes by mir-124486-5-mapk1 axis. Cell Mol Biol Lett. 2023;28(1):101. https:\/\/doi.org\/10.1186\/s11658-023-00515-z.","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"2386_CR66","doi-asserted-by":"publisher","first-page":"e14473","DOI":"10.1111\/cbdd.14473","volume":"103","author":"J Zhou","year":"2024","unstructured":"Zhou J, Yao L, Su Y, Tian L. Igf2bp3 loss inhibits cell progression by upregulating has_circrna_103820, and hsa_circrna_103820-encoded peptide inhibits cell progression by inactivating the akt pathway in lung cancer. Chem Biol Drug Des. 2024;103(2):e14473. https:\/\/doi.org\/10.1111\/cbdd.14473.","journal-title":"Chem Biol Drug Des"},{"key":"2386_CR67","doi-asserted-by":"publisher","first-page":"154950","DOI":"10.1016\/j.prp.2023.154950","volume":"253","author":"X Zhong","year":"2024","unstructured":"Zhong X, Peng Y, Zhang X, Peng L, Ma K, Huang Y, Yang X. M6a-modified circ_0124554 promotes colorectal cancer progression and radioresistance through the mir-1184\/lasp1 pathway. Pathol Res Pract. 2024;253:154950. https:\/\/doi.org\/10.1016\/j.prp.2023.154950.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"2386_CR68","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-024-02965-5","volume":"43","author":"K Chen","year":"2024","unstructured":"Chen K, Zhang J, Meng L, Kong L, Lu M, Wang Z, Wang W. The epigenetic downregulation of lncghrlos mediated by rna m6a methylase zcchc4 promotes colorectal cancer tumorigenesis. J Exp Clin Cancer Res. 2024;43(1):44. https:\/\/doi.org\/10.1186\/s13046-024-02965-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2386_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12935-024-03250-3","volume":"24","author":"X Ji","year":"2024","unstructured":"Ji X, Wan X, Sun H, Deng Q, Meng S, Xie B, Zhou S. Mettl14 enhances the m6a modification level of lncrna mstrg.292666.16 to promote the progression of non-small cell lung cancer. Cancer Cell Int. 2024;24(1):61. https:\/\/doi.org\/10.1186\/s12935-024-03250-3.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2386_CR70","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13008-024-00110-4","volume":"19","author":"Z Yang","year":"2024","unstructured":"Yang Z, Luo Y, Zhang F, Ma L. Exosome-derived lncrna a1bg-as1 attenuates the progression of prostate cancer depending on zc3h13-mediated m6a modification. Cell Div. 2024;19(1):5. https:\/\/doi.org\/10.1186\/s13008-024-00110-4.","journal-title":"Cell Div"},{"issue":"1","key":"2386_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12935-024-03240-5","volume":"24","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chang L, Liang Q, Zhao R, Xiao Y, Xu Z, Yu L. The m6a methyltransferase mettl3 drives thyroid cancer progression and lymph node metastasis by targeting linc00894. Cancer Cell Int. 2024;24(1):47. https:\/\/doi.org\/10.1186\/s12935-024-03240-5.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"2386_CR72","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, Chen Y, Sulman EP, Xie K, Bogler O, Majumder S, He C, Huang S. M(6)a demethylase alkbh5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining foxm1 expression and cell proliferation program. Cancer Cell. 2017;31(4):591\u2013606. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.013.","journal-title":"Cancer Cell"},{"issue":"1","key":"2386_CR73","doi-asserted-by":"publisher","first-page":"113712","DOI":"10.1016\/j.yexcr.2023.113712","volume":"430","author":"L Liang","year":"2023","unstructured":"Liang L, Liu S, Wu Q, Chen R, Jiang S, Yang Z. M6a-mediated upregulation of mirna-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the mettl3\/ mirna-193a\/bcl2l2 pathway. Exp Cell Res. 2023;430(1):113712. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113712.","journal-title":"Exp Cell Res"},{"issue":"13","key":"2386_CR74","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1158\/0008-5472.CAN-22-0065","volume":"83","author":"S Li","year":"2023","unstructured":"Li S, Du M, Xu K, Ben S, Zhu T, Guo M, Xin J, Zhu L, Gu D, Zhang Z, Wang M. Genetic modulation of bet1l confers colorectal cancer susceptibility by reducing mirna binding and m6a modification. Cancer Res. 2023;83(13):2142\u201354. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0065.","journal-title":"Cancer Res"},{"issue":"9","key":"2386_CR75","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1152\/physiolgenomics.00007.2022","volume":"54","author":"Y Gong","year":"2022","unstructured":"Gong Y, Jiang Q, Liu L, Liao Q, Yu J, Xiang Z, Luo X. Mettl3-mediated m6a modification promotes processing and maturation of pri-mirna-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion. Physiol Genomics. 2022;54(9):337\u201349. https:\/\/doi.org\/10.1152\/physiolgenomics.00007.2022.","journal-title":"Physiol Genomics"},{"issue":"3","key":"2386_CR76","doi-asserted-by":"publisher","first-page":"C770","DOI":"10.1152\/ajpcell.00136.2023","volume":"325","author":"H Liang","year":"2023","unstructured":"Liang H, Fang C, Zhang L. Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via n6-methyladenosine methylation. Am J Physiol Cell Physiol. 2023;325(3):C770\u20139. https:\/\/doi.org\/10.1152\/ajpcell.00136.2023.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2386_CR77","doi-asserted-by":"publisher","first-page":"110058","DOI":"10.1016\/j.intimp.2023.110058","volume":"119","author":"N Guo","year":"2023","unstructured":"Guo N, Song Y, Zi F, Zheng J, Cheng J. Abnormal expression pattern of lncrna h19 participates in multiple myeloma bone disease by unbalancing osteogenesis and osteolysis. Int Immunopharmacol. 2023;119:110058. https:\/\/doi.org\/10.1016\/j.intimp.2023.110058.","journal-title":"Int Immunopharmacol"},{"key":"2386_CR78","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20231186","author":"S Chen","year":"2024","unstructured":"Chen S, Duan X, He Y, Chen W. Mettl3 promotes osteogenic differentiation of human umbilical cord mesenchymal stem cells by upregulating m6a modification of circcttn. 2024. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20231186."},{"key":"2386_CR79","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13607","author":"H Yang","year":"2024","unstructured":"Yang H, Wang W, Liu H, Zhang C, Cao Y, Long L, Han X, Wang Y, Yan F, Li G, Zhu M, Jin L, Fan Z. Mir615\u20133p inhibited fbln1 and osteogenic differentiation of umbilical cord mesenchymal stem cells by associated with ythdf2 in a m(6) a-mirna interaction manner. Cell Prolif. 2024. https:\/\/doi.org\/10.1111\/cpr.13607.","journal-title":"Cell Prolif"},{"issue":"18","key":"2386_CR80","doi-asserted-by":"publisher","first-page":"7760","DOI":"10.7150\/thno.76852","volume":"12","author":"R Liu","year":"2022","unstructured":"Liu R, Zhong Y, Chen R, Chu C, Liu G, Zhou Y, Huang Y, Fang Z, Liu H. M(6)a reader hnrnpa2b1 drives multiple myeloma osteolytic bone disease. Theranostics. 2022;12(18):7760\u201374. https:\/\/doi.org\/10.7150\/thno.76852.","journal-title":"Theranostics"},{"issue":"3","key":"2386_CR81","doi-asserted-by":"publisher","first-page":"C684","DOI":"10.1152\/ajpcell.00348.2023","volume":"326","author":"L Yao","year":"2024","unstructured":"Yao L, Li T, Teng Y, Guo J, Zhang H, Xia L, Wu Q. Alkhb5-demethylated lncrna snhg15 promotes myeloma tumorigenicity by increasing chromatin accessibility and recruiting h3k36me3 modifier setd2. Am J Physiol Cell Physiol. 2024;326(3):C684\u201397. https:\/\/doi.org\/10.1152\/ajpcell.00348.2023.","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02386-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02386-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02386-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T15:49:54Z","timestamp":1745596194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02386-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2386"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02386-6","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20231186","asserted-by":"subject"}]},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"615"}}